
| Drug Use and HIV Vulnerability (UNAIDS, 2001, 238 p.) |
| (introduction...) |
| Foreword |
| Acknowledgements |
| Chapter 1: Main report |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Drug use and HIV/AIDS in the study-countries |
![]() | B. The drug laws in the study-countries |
![]() | C. Drug and HIV policies |
![]() | D. Risk reduction strategies: experience in the study-countries |
![]() | E. Reducing the harms: constraining and facilitating factors |
![]() | V. Discussion |
| Chapter 2: People's Republic of China |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Epidemiology of drug use |
![]() | B. Mechanisms for drug control |
![]() | C. Drug treatment |
![]() | D. HIV/AIDS |
![]() | E. Prevention and control of HIV/AIDS |
![]() | V. Discussion |
![]() | A. Constraining factors |
![]() | B. Estimating the size of the drug problem: data gathering |
| Chapter 3: India |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Patterns of drug use |
![]() | B. Epidemiology of drug use |
![]() | C. Treatment and rehabilitation |
![]() | D. Mechanisms for drug control |
![]() | E. HIV/AIDS |
![]() | F. HIV/AIDS prevention |
![]() | V. Discussion |
![]() | A. Constraining factors |
![]() | B. Facilitators, levers and opportunities |
| Chapter 4: Malaysia |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Patterns of drug use |
![]() | B. Epidemiology of drug use |
![]() | C. Government responses to drug use |
![]() | D. Legislation and application of laws |
![]() | E. Evaluation of law enforcement strategies |
![]() | F. Risk of HIV infection in prisons |
![]() | G. Treatment and rehabilitation |
![]() | H. HIV/AIDS |
![]() | V. Discussion |
![]() | A. Constraining factors |
![]() | B. Facilitating factors |
| Chapter 5: Myanmar |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Drug use in Myanmar |
![]() | B. Mechanisms for drug control |
![]() | C. Approaches to treatment and rehabilitation |
![]() | D. HIV/AIDS |
![]() | E. HIV/AIDS and drug use |
![]() | V. Discussion |
![]() | (introduction...) |
![]() | A. Constraining factors |
![]() | B. Facilitating factors |
| Chapter 6: Nepal |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Epidemiology of drug use |
![]() | B. Treatment and rehabilitation |
![]() | C. Current drug policy |
![]() | D. Drug policy development |
![]() | E. HIV/AIDS |
![]() | V. Discussion |
![]() | A. Constraining factors |
![]() | B. Facilitating factors |
| Chapter 7: Thailand |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Epidemiology of drug use |
![]() | B. Trends of drug use |
![]() | C. Drug policy in Thailand |
![]() | D. HIV/AIDS |
![]() | V. Discussion |
![]() | A. Constraining factors |
![]() | B. Facilitating factors |
| Chapter 8: Viet Nam |
![]() | I. Summary of findings |
![]() | II. Recommendations |
![]() | III. Introduction |
![]() | IV. Findings |
![]() | A. Drug use in Viet Nam |
![]() | B. Mechanisms for drug control |
![]() | C. Treatment and rehabilitation |
![]() | D. HIV/AIDS |
![]() | V. Discussion |
![]() | (introduction...) |
![]() | A. Constraining factors |
![]() | B. Facilitating factors |
| References |
| Annexes |
![]() | Annex 1: Terms used in this report |
![]() | Annex 2: How prevalence and incidence data are derived |